SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-22-088386
Filing Date
2022-03-30
Accepted
2022-03-29 19:04:18
Documents
64
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d275568d10k.htm   iXBRL 10-K 2279563
2 EX-23.1 d275568dex231.htm EX-23.1 1447
3 EX-31.1 d275568dex311.htm EX-31.1 10537
4 EX-31.2 d275568dex312.htm EX-31.2 10143
5 EX-32.1 d275568dex321.htm EX-32.1 5565
11 GRAPHIC g275568g01t13.jpg GRAPHIC 140201
12 GRAPHIC g275568g63d12.jpg GRAPHIC 169259
13 GRAPHIC g275568g76b42.jpg GRAPHIC 236957
  Complete submission text file 0001193125-22-088386.txt   7828829

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cmpi-20211231.xsd EX-101.SCH 37236
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmpi-20211231_cal.xml EX-101.CAL 37393
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmpi-20211231_def.xml EX-101.DEF 196287
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpi-20211231_lab.xml EX-101.LAB 355477
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpi-20211231_pre.xml EX-101.PRE 284559
58 EXTRACTED XBRL INSTANCE DOCUMENT d275568d10k_htm.xml XML 708574
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39425 | Film No.: 22782588
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences